Completed Access to Information Requests

Follow:

  • RSS
  • Cite
About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Report Type

Organization

Disposition

Year

Month

Found 63431 record(s)

Req # A-2021-001963

Adverse Drug Reactions (ADRs). Report numbers: 000970814, E2B_04790824, E2B_04737471, E2B_04737542.

Organization: Health Canada

69 page(s)
May 2022

Req # A-2021-001980

Adverse Drug Reactions (ADRs). Report numbers: E2B_04765128, E2B_04807541, E2B_04824570, E2B_04821006, 000973481, E2B_04756344, 000972259, 000970522, 000973760, 000973872, 000972425, E2B_01038775, E2B_01668238, E2B_04750565, E2B_04753860, E2B_04785866, E2B_04831127, 000726401.

Organization: Health Canada

447 page(s)
May 2022

Req # A-2021-001989

Adverse Drug Reactions (ADRs) for Hydromorphone. Report numbers: E2B_04820013, 000971865. ADR for Balversa. Report number: E2B_03466185. ADRs for Midazolam. Report numbers: E2B_04781876, E2B_04781873.

Organization: Health Canada

166 page(s)
May 2022

Req # A-2021-002015

Adverse Drug Reaction (ADR) for PMS-SERTRALINE/PMS-QUETIAPINE. Report number: 000968992. ADRs for CLIOQUINOL/FLUMETHASONE PIVALATE. Report numbers: E2B_03328390, E2B_00900035, E2B_00483641.

Organization: Health Canada

377 page(s)
May 2022

Req # A-2021-002039

Adverse Drug Reactions (ADRs). Report numbers: E2B_04904096, E2B_04938389, E2B_04938394, E2B_04894243, 975179.

Organization: Health Canada

48 page(s)
May 2022

Req # A-2021-002041

Adverse Drug Reactions (ADRs). Report numbers: 000965936, 000968726.

Organization: Health Canada

8 page(s)
May 2022

Req # A-2021-002045

Adverse Drug Reactions (ADRs). Report numbers: 951705, 948797, 948430, 951918, 948429, 950383, 952132, 948806, 948427, 948564, 951548, 948733, 949681, 948968, E2B_04215767, 953394, 948395, 949763, 955947, E2B_04279981.

Organization: Health Canada

280 page(s)
May 2022

Req # A-2021-002049

Adverse Drug Reaction (ADR) for Eculizumab. Report number: E2B_04788657.

Organization: Health Canada

17 page(s)
May 2022

Req # A-2021-002055

Adverse Drug Reaction (ADR) for FUROSEMIDE. Report number: E2B_04875745.

Organization: Health Canada

20 page(s)
May 2022

Req # A-2021-002075

Adverse Drug Reactions (ADRs). Report numbers: E2B_03242218, E2B_03790563.

Organization: Health Canada

36 page(s)
May 2022
Date modified: